895P Cost effectiveness of stereotactic ablative radiotherapy (SABR) alone in comparison with systemic treatment and SABR in oligometastatic head and neck cancer in the GORTEC 2014-04 OMET randomized phase II study

Autor: Thariat, J., Falcoz, A., Nadin, L., Bourhis, J., Sun, X., Nerich, V.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S634-S634
Databáze: ScienceDirect